P. JACOBSEN

Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.

L. Turski, P. JACOBSEN, T. Honoré et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 86 citations

Medicine, Neuroscience, Pharmacology +16

(<i>S</i>)‐Carboxy‐3‐Hydroxyphenylglycine, an Antagonist of Metabotropic Glutamate Receptor (mGluR)1a and an Agonist of mGluR2, Protects Against Audiogenic Seizures in DBA/2 Mice

Christian Thomsen, Henrik Klitgaard, Malcolm J. Sheardown et al. · Journal of Neurochemistry · 1994 · 59 citations

Life Sciences, Neuroscience, Pharmacology +17

The antiparkinsonian agent budipine is an N-methyl-D-aspartate antagonist

Thomas Klockgether, P. JACOBSEN, P.-A. Löschmann et al. · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · 1993 · 53 citations

Medicine, Pharmacology, Pharmacotherapy +5

Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).

Michael D.B. Swedberg, P. JACOBSEN, T. Honoré · Journal of Pharmacology and Experimental Therapeutics · 1995 · 48 citations

Medicine, Neuroscience, Pharmacology +15

Synthesis and pharmacology of a novel pyrrolo[2,1,5-cd]indolizine (NNC 45-0095), a high affinity non-steroidal agonist for the estrogen receptor

Anker Jørgensen, P. JACOBSEN, L. Christiansen et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 44 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17